<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Golden Triangle Consultants News and Insights</title>
<link>https://goldentriangleconsultants.com/news-and-insights/</link>
<description>Pharmaceutical pricing, market access, IRP, HTA and AI insights from Golden Triangle Consultants.</description>
<language>en-gb</language>
<lastBuildDate>Wed, 16 Sep 2026 19:43:33 +0000</lastBuildDate>
<atom:link href="https://goldentriangleconsultants.com/feed.xml" rel="self" type="application/rss+xml" />
<item>
<title>Golden Triangle Consultants at World EPA Congress 2026</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-world-epa-2026/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-world-epa-2026/</guid>
<pubDate>Tue, 24 Feb 2026 00:00:00 +0000</pubDate>
<description>Golden Triangle Consultants will attend the World Evidence, Pricing and Access Congress 2026 in Amsterdam on 3–4 March.</description>
</item>
<item>
<title>Could US Reboot Signal the Value Based Pricing Tipping Point?</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/could-us-reboot-signal-the-value-based-pricing-tipping-point/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/could-us-reboot-signal-the-value-based-pricing-tipping-point/</guid>
<pubDate>Wed, 23 Jul 2025 00:00:00 +0000</pubDate>
<description>High-cost advanced therapies, outcomes-based agreements and stronger evidence capabilities may be pushing value-based pricing into a new phase.</description>
</item>
<item>
<title>Saudi HTA July 2025: Gulf &amp; Global Pricing Implications</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/saudi-hta-july-2025-gulf-global-pricing-implications/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/saudi-hta-july-2025-gulf-global-pricing-implications/</guid>
<pubDate>Tue, 15 Jul 2025 00:00:00 +0000</pubDate>
<description>Saudi Arabia’s move towards economic evaluation adds a value-based layer to a market already influential through IRP and Gulf procurement.</description>
</item>
<item>
<title>Canada Finalises PMPRB Drug Pricing Rules: Key Takeaways</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/canada-finalises-pmprb-drug-pricing-rules-key-takeaways/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/canada-finalises-pmprb-drug-pricing-rules-key-takeaways/</guid>
<pubDate>Wed, 02 Jul 2025 00:00:00 +0000</pubDate>
<description>Canada’s June 2025 PMPRB Guidelines changed how staff identify patented medicines for potential excessive-price review.</description>
</item>
<item>
<title>Global Ripple Effects of the U.S. “MFN” Pricing Order</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/global-ripple-effects-of-the-us-“mfn”-pricing-order/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/global-ripple-effects-of-the-us-“mfn”-pricing-order/</guid>
<pubDate>Thu, 22 May 2025 00:00:00 +0000</pubDate>
<description>The May 2025 US Most-Favoured-Nation drug-pricing order raised implications for launch sequencing, list-price strategy and international reference pricing.</description>
</item>
<item>
<title>EU HTA Goes Live: What the JCA Means for Access, Pricing &amp; IRP</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/eu-hta-goes-live-what-the-jca-means-for-access-pricing-irp/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/eu-hta-goes-live-what-the-jca-means-for-access-pricing-irp/</guid>
<pubDate>Mon, 14 Apr 2025 00:00:00 +0000</pubDate>
<description>The EU HTA Regulation began applying in 2025, introducing Joint Clinical Assessments and changing evidence planning across Europe.</description>
</item>
<item>
<title>Bracing for 22.9%: What the 2025 VPAG Payback Rate Means</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/bracing-for-229-what-the-2025-vpag-payback-rate-means/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/bracing-for-229-what-the-2025-vpag-payback-rate-means/</guid>
<pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
<description>The 2025 VPAG payment percentage for eligible newer medicines was 22.9%, creating important UK forecasting and launch-strategy considerations.</description>
</item>
<item>
<title>GTC Returns to EPA</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/gtc-returns-to-epa/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/gtc-returns-to-epa/</guid>
<pubDate>Tue, 05 Mar 2024 00:00:00 +0000</pubDate>
<description>Golden Triangle Consultants returned to the World Evidence, Pricing and Access Congress in Amsterdam in 2024.</description>
</item>
<item>
<title>AI vs. Health Economists: Can ChatGPT Build Budget Impact Models?</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/ai-vs-health-economists-can-chat-gpt-build-budget-impact-models/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/ai-vs-health-economists-can-chat-gpt-build-budget-impact-models/</guid>
<pubDate>Thu, 20 Apr 2023 00:00:00 +0000</pubDate>
<description>A practical early experiment testing whether ChatGPT could guide the construction of a simple pharmaceutical budget impact model in Excel.</description>
</item>
<item>
<title>AI-Generated Content in Pharmaceuticals: A Cautionary Tale</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/ai-generated-content-in-pharmaceuticals-a-cautionary-tale/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/ai-generated-content-in-pharmaceuticals-a-cautionary-tale/</guid>
<pubDate>Wed, 05 Apr 2023 00:00:00 +0000</pubDate>
<description>An early generative-AI experiment in pharma showed impressive fluency alongside a serious risk of fabricated evidence and references.</description>
</item>
<item>
<title>Golden Triangle Consultants at EPA 2023</title>
<link>https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-epa-2023/</link>
<guid isPermaLink="true">https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-epa-2023/</guid>
<pubDate>Wed, 15 Mar 2023 00:00:00 +0000</pubDate>
<description>Golden Triangle Consultants attended the World Evidence, Pricing and Access Congress 2023 in Amsterdam.</description>
</item>
</channel>
</rss>
